Abstract：【Objective】 To explore the effect of programmatic management on disease self-management ability and quality of life in patients with rheumatic and immune diseases.【Methods】 A total of 72 patients with rheumatic and immune diseases were randomly divided into an observation group (receiving programmatic management based on routine management,n=36) and a control group (receiving routine management alone,n=36). Disease self-management ability, pain level, quality of life, and medication adherence were compared between the two groups before and after the intervention.【Results】 After 3 months of intervention, scores for exercise, cognitive symptom management, and communication with physicians in the disease self-management ability scale were significantly higher in the observation group than in the control group (P<0.05). Pain scores in the observation group were lower than those in the control group (P<0.05). Scores for physical, psychological, social, and material functions in the quality-of-life scale were all higher in the observation group compared to the control group (P<0.05). Medication adherence in the observation group was also higher than that in the control group(P<0.05).【Conclusion】 Programmatic management can significantly enhance disease self-management ability, effectively relieve pain symptoms, comprehensively improve quality of life, and increase medication adherence in patients with rheumatic and immune diseases, demonstrating clinical value in optimizing comprehensive disease management.
李瑞丽, 焦亚婷, 赖亚南. 程序化管理对风湿免疫性疾病患者疾病自我管理能力及生活质量的影响[J]. 医学临床研究, 2025, 42(12): 2104-2106.
LI Ruili, JIAO Yating, LAI Yanan. Effect of Programmatic Management on Disease Self-Management Ability and Quality of Life in Patients with Rheumatic and Immune Diseases. JOURNAL OF CLINICAL RESEARCH, 2025, 42(12): 2104-2106.
2025, Vol. 42 
